DRUGS AND MEDICINES: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS (2026-10-1820)

DRUGS AND MEDICINES: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS (2026-10-1820) Item Description ABC Unit Quantity 1 ABIRATERONE ACETATE 250MG TABLET 6,000,000.00 TABLET 12,000.00 2 ATEZOLIZUMAB 60MG/ML, 20ML VIAL FOR INTRAVENOUS INFUSION (IV) 2,933,035.80 VIAL 30.00 3 BEVACIZUMAB 25MG/ML 4ML VIAL (IV INFUSION) 2,600,000.00 VIAL 400.00 4 BEVACIZUMAB 25MG/ML, 16ML VIAL FOR IV INFUSION 1,469,349.60 VIAL 30.00 5 BICALUTAMIDE 50MG TABLET OR FILM-COATED TABLET 28,800.00 TABLET 1,200.00 6 DACTINOMYCIN 500MCG POWDER, VIAL (IV) 12,000.00 VIAL 20.00 7 ETOPOSIDE 20MG/ML, 5ML AMPULE OR VIAL (IV) 90,000.00 PIECE 600.00 8 GEFITINIB 250MG TABLET OR FILM-COATED TABLET 11,117,190.00 TABLET 5,010.00 9 GOSERELIN ACETATE 3.6MG DEPOT SOLUTION PRE-FILLED SYRINGE (SC) 823,760.00 PFS 200.00 10 HYDROXYUREA 500MG CAPSULE 27,900.00 CAPSULE 900.00 11 IFOSFAMIDE 2G POWDER VIAL 597,000.00 VIAL 300.00 12 LENVATINIB 10MG CAPSULE 2,300,000.00 CAPSULE 500.00 13 MESNA (SODIUM-2-MERCAPTOETHANESULPHONATE) 100MG/ML, 4ML AMPULE (IV) 115,500.00 AMPULE 700.00 14 METHOTREXATE SODIUM 25MG/ML, 2ML AMPULE OR VIAL 45,000.00 PIECE 200.00 15 MYCOPHENOLIC ACID (AS MYCOPHENOLATE MOFETIL) 500MG TABLET 125,000.00 TABLET 2,500.00 16 VINBLASTINE SULFATE 1MG/ML, 10ML VIAL (IV) 63,000.00 VIAL 30.00 TERMS OF REFERENCE 4TH QUARTER PUBLIC BIDDING TO ENSURE AVAILABILITY AND ADMINISTRATION OF ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS P.R. # 2026-10-1820 The drug & medicine should have at least 18 months of expiration from the delivery date. The winning bidder however may provide a guarantee letter to pull-out and replace near expiry items 3 months prior to expiration date once the expiration date is lower than 18 months. Acceptance of near expiry medicines will depend on the need of the Pharmacy Section and the approval of Materials Management Section Head. Pharmacy Section will have the option to retain 3 months projection of near expiry medicines if no longer expiry is available. In the event that supplier fails to pull-out expired items 3 months prior to date of expiry, it will be automatically considered as pulled-out and will be reflected as deduction from the supplier’s account. All suppliers to attach return policy even for more than 18 month expiry. Suppliers must provide FDA License to Operate (LTO) as Drug Wholesaler, and Certificate of Sub – distributorship from the manufacturer or distributor if the supplier’s company name does not appear in the CPR. Suppliers must provide FDA Certificate of Product Registration (CPR) Suppliers must provide FDA Certificate of Good Manufacturing Practice (CGMP) All labels/packaging of all drugs & medicines must have a readable Name of Drug, Lot Number, Manufacturing and Expiration Date. The following drugs and medicines should be provided with a safety data sheet (SDS) consisting of sixteen (16) sections and updated within five (5) years upon or during delivery. If no changes have been made, a certification letter should accompany the SDS to substantiate the claim: BEVACIZUMAB 25MG/ML 4ML VIAL (IV INFUSION) BEVACIZUMAB 25MG/ML, 16ML VIAL FOR IV INFUSION DACTINOMYCIN 500MCG POWDER, VIAL (IV) ETOPOSIDE 20MG/ML, 5ML AMPULE OR VIAL (IV) GOSERELIN ACETATE 3.6MG DEPOT SOLUTION PRE-FILLED SYRINGE (SC) IFOSFAMIDE 2G POWDER VIAL MESNA (SODIUM-2-MERCAPTOETHANESULPHONATE) 100MG/ML, 4ML AMPULE (IV) METHOTREXATE SODIUM 25MG/ML, 2ML AMPULE OR VIAL VINBLASTINE SULFATE 1MG/ML, 10ML VIAL (IV) Pre-bid Conference Date Time Venue 12/11/2026 9:00 AM at the REODICA HALL which can also be viewed via GOOGLE MEET with the following details: Join with Google Meet: Link: https://meet.google.com/emq-rtig-ihe Other Information Kindly see attached Public Bidding Documents Created by Ma. Christina C. Pabicon Date Created 29/10/2026 The PhilGEPS team is not responsible for any typographical errors or misinformation presented in the system. PhilGEPS only displays information provided for by its clients, and any queries regarding the postings should be directed to the contact person/s of the concerned party. ©&nbsp2004-2026 DBM Procurement Service. All rights reserved. Help | Contact Us | Sitemap